VitaNova Life Sciences (VNOV) Market Capitalization (2022 - 2026)

VitaNova Life Sciences has disclosed Market Capitalization across 5 years of filings, most recently posting $11.5 million for Q3 2026.

• Market Capitalization for Q3 2026 came in at $11.5 million, down 14.81% year-over-year; the trailing twelve-month figure through Jul 2026 was $11.5 million (down 14.81% YoY), and the FY2026 annual result was $11.5 million, down 14.81% from the prior year.
• Market Capitalization for Q3 2026 stood at $11.5 million, roughly flat from $11.5 million in the prior quarter.
• Across five years, Market Capitalization topped out at $120.8 million in Q4 2025 and bottomed at $9.0 million in Q2 2022.
• Average Market Capitalization over 5 years is $26.9 million, with a median of $13.5 million recorded in 2024.
• The widest annual swing landed in 2024, when Market Capitalization plunged 74.18%; it then soared 794.44% in 2025.
• Year by year, Market Capitalization stood at $35.2 million in 2022, then sank by 70.0% to $10.6 million in 2023, then rose by 27.8% to $13.5 million in 2024, then jumped by 794.44% to $120.8 million in 2025, then sank by 90.48% to $11.5 million in 2026.
• The last three Market Capitalization figures came in at $11.5 million (Q3 2026), $11.5 million (Q2 2026), and $40.3 million (Q1 2026), per Business Quant data.